Fatty Acid Induced Metabolomics (FAIM) Study

During the third trimester of pregnancy the placenta selectively transfers fatty acids to the baby, particularly docosahexaenoic acid (DHA) and arachidonic acid (ARA). These nutrients are critical building blocks for brain and eye development and are important for proper functioning of the immune system. Preterm infants largely miss the last trimester and rely on intravenous nutrition, human milk, and formula to provide these fatty acids. However, despite these nutritional sources, preterm babies develop DHA and ARA deficiencies. As of today, we don't know the best way to improve DHA and ARA status in preterm babies.  Recently, a DHA & ARA supplement was made available. In this study, we hope to better understand how this supplement alters DHA and ARA status and how babies breakdown (or metabolize) these fatty acids.